Brief: Janux Therapeutics Reports Fourth Quarter And Full Year 2023 Financial Results And Business Highlights

Janux Therapeutics

08/03/2024 21:25

March 8 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2023
FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
    * JANUX THERAPEUTICS INC - UPDATE ON JANX007 DATA AND DOSES
SELECTED FOR EXPANSION COHORTS IS ANTICIPATED IN 2H 2024
    * JANUX THERAPEUTICS INC - ENROLLMENT ONGOING FOR JANX007
AND
JANX008
    * JANUX THERAPEUTICS INC: AS OF DECEMBER 31, 2023, JANUX
REPORTED
CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $344.0
MILLION

Source text for Eikon:  ID:nBw2zwzN4a 
Further company coverage:  JANX.O